[1] 路文, 桑延智.经玻璃体切除全视网膜激光光凝术联合玻璃体腔注射康柏西普治疗增生期糖尿病性视网膜病变的疗效观察[J].中国激光医学杂志, 2018, 27(2):147-148. Lu W, Sang Y Z. Observation on the efficacy of total retinal laser photocoagulation combined with intravitreal injection of Compoxip in the treatment of proliferative diabetic retinopathy[J]. Chinese Journal of Laser Medicine, 2018, 27(2):147-148.
[2] Dehghani A, Ghanbari H, Mahdizadeh A, et al. Single-dose intravitreal bevacizumab after complete panretinal photocoagulation in proliferative diabetic retinopathy:an effective adjunctive treatment[J]. Medical Hypothesis Discovery & Innovation Ophthalmology Journal, 2017, 6(3):76-81.
[3] Nikkhah H, Ghazi H, Razzaghi M R, et al. Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial[J]. International Ophthalmology, 2018, 38(1):313-321.
[4] 张鹏飞, 张杰, 高荣玉, 等.玻璃体内注射血管内皮生长因子(VEGF)抑制剂治疗糖尿病视网膜病变患者的疗效[J].眼科新进展, 2018, 38(10):977-981. Zhang P F, Zhang J, Gao R Y, et al. Curative effect of intravitreal injection of vascular endothelial growth factor (VEGF) inhibitor on patients with diabetic retinopathy[J]. New Progress in Ophthalmology, 2018, 38(10):977-981.
[5] 张石华, 戴莉, 李晓雯.玻璃体腔注射康柏西普联合激光光凝对糖尿病视网膜病变患者症状改善及血清bFGF IGF-1 VEGF水平变化的影响[J].中国药物与临床, 2018, 18(10):1667-1670. Zhang S H, Dai L, Li X W. The effect of intravitreal injection of Compoxip combined with laser photocoagulation on the improvement of symptoms and changes of serum bFGF, IGF-1 and VEGF levels in patients with diabetic retinopathy[J]. Chinese Medicine and Clinical, 2018, 18(10):1667-1670.
[6] 中华医学会眼科学会眼底病学组.我国糖尿病视网膜病变临床诊疗指南(2014年)[J].中华眼科杂志, 2014, 50(11):851-865. Ophthalmology Group, Ophthalmological Society of Chinese Medical Association. Guidelines for clinical diagnosis and treatment of diabetic retinopathy (2014)[J]. Chinese Journal of Ophthalmology, 2014, 50(11):851-865.
[7] 刘爱琴, 宋子宣.改良视网膜光凝术治疗糖尿病视网膜病变的效果及其对血清血管内皮生长因子和内皮素-1水平的影响[J].新乡医学院学报, 2019, 36(4):372-375. Liu A Q, Song Z X. Effect of modified retinal photocoagulation on diabetic retinopathy and its effect on serum levels of vascular endothelial growth factor and endothelin-1[J]. Journal of Xinxiang Medical College, 2019, 36(4):372-375.
[8] 许艳, 姚晶磊, 陈冬梅,等.改良与传统全视网膜光凝术治疗糖尿病视网膜病变疗效观察[J].眼科新进展, 2017, 37(12):1178-1181. Xu Y, Yao J L, Chen D M, et al. Observation of the therapeutic effect of modified and traditional panretinal photocoagulation on diabetic retinopathy[J].New Progress in Ophthalmology, 2017, 37(12):1178-1181.
[9] Gross J G, Glassman A R, Liu D, et al.Five-year outcomes of panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy:a randomized clinical trial[J].JAMA Ophthalmology, 2018, 136(10):1138-1148.
[10] Torp T L, Kawasaki R, Wong T Y, et al. Temporal changes in retinal vascular parameters associated with successful panretinal photocoagulation in proliferative diabetic retinopathy:a prospective clinical interventional study[J].Acta Ophthalmologica, 2018, 96(4):405-410.
[11] Wang L P, Li H M. Clinical research of intravitreal injection of Conbercept combined with different methods in the treatment of neovascular glaucoma[J]. International Eye Science, 2017, 17(2):332-334.
[12] Obeid A, Su D, Patel S N, et al. Outcomes of eyes lost to follow-up with proliferative diabetic retinopathy that received panretinal photocoagulation versus intravitreal anti-vascular endothelial growth factor[J]. Ophthalmology, 2019, 126(3):407-413.
[13] 卜倩, 高云仙, 阿依努·努拉厚, 等.康柏西普联合激光对DR患者炎症因子、氧化应激水平及视网膜血流动力学的影响[J].国际眼科杂志, 2018, 18(8):1443-1446. Bu Q, Gao Y X, Ayinu·Nulahou, et al. Effects of Compassip combined with laser on inflammatory factors, oxidative stress and retinal hemodynamics in patients with DR[J]. International Journal of Ophthalmology, 2018, 18(8):1443-1446.
[14] 曾广川, 李萍萍, 叶阳君.玻璃体腔注射康柏西普对PDR玻璃体切割的辅助作用[J].中华实验眼科杂志, 2017, 35(10):920-923. Zeng G C, Li P P, Ye Y J. Auxiliary effect of intravitreal injection of Compoxip on PDR vitrectomy[J]. Chinese Journal of Experimental Ophthalmology, 2017, 35(10):920-923.
[15] Zhang X, Wu C, Zhou L J, et al. Observation of optic disc neovascularization using OCT angiography in proliferative diabetic retinopathy after intravitreal conbercept injections[J]. Scientific Reports, 2018, 8(1):3972.
[16] 李隽, 徐国兴.玻璃体切除术前注射抗VEGF类药物治疗PDF的疗效及安全性的Meta分析[J].国际眼科杂志, 2017, 17(8):1446-1456. Li J, Xu G X. Meta-analysis of the efficacy and safety of anti-vascular drugs in the treatment of PDF before vitrectomy[J].International Eye Science, 2017, 17(8):1446-1456.
[17] 陈震, 张雨, 聂玉红.全视网膜激光光凝联合不同药物对PDR患者视网膜厚度、BCVA和N1波潜伏期的影响比较[J].临床和实验医学杂志, 2019, (14):1552-1554. Chen Z, Zhang Y, Nie Y H. Comparison of retinal thickness, BCVA and N1 wave latency in PDR patients treated with panretinal laser photocoagulation combined with different drugs[J]. Journal of Clinical and Experimental Medicine, 2019, (14):1552-1554.
[18] Hutton D W, Stein J D, Bressler N M, et al. Cost-effectiveness of intravitreous ranibizumab compared with panretinal photocoagulation for proliferative diabetic retinopathy:secondary analysis from a diabetic retinopathy clinical research network randomized clinical trial[J]. JAMA Ophthalmology, 2017, 135(6):576-584. |